Cardiovasc Intervent Radiol (2017) 40:1372–1382 DOI 10.1007/s00270-017-1655-8 CLINICAL INVESTIGATION VENOUS INTERVENTIONS Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus 1,4 2 3 1 • • • Bin Qiu Kai Li Xiaoqun Dong Fu-Quan Liu Received: 10 December 2016 / Accepted: 18 April 2017 / Published online: 9 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract The symptoms of portal hypertension were well relieved. Purpose In patients with hepatocellular carcinoma (HCC), Variceal bleeding was successfully controlled and termi- limited therapeutic options are available for portal hyper- nated in 100% of patients, with a recurrence rate of 39.2% tension resulted from portal vein tumor thrombus (PVTT). in 12 months. Refractory ascites/hydrothorax was con- We aimed to determine safety and efﬁcacy of TIPS for trolled partially or completely in 92.9% of patients during treatment of symptomatic portal hypertension in HCC with 1 month after TIPS, with a recurrence rate of 17.9% in PVTT. 12 months. Survival rate at 6, 12, 24, and 36 months was Methods We evaluated clinical characteristics of 95 75.8, 52.7, 26.4, and 3.3%, respectively. No unexpected patients with HCC and
CardioVascular and Interventional Radiology – Springer Journals
Published: May 9, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera